Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Current Deferred Revenue (2016 - 2025)

Jaguar Health (JAGX) has disclosed Current Deferred Revenue for 6 consecutive years, with $170000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Current Deferred Revenue changed 0.0% to $170000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $170000.0, a 0.0% change, with the full-year FY2024 number at $170000.0, changed N/A from a year prior.
  • Current Deferred Revenue was $170000.0 for Q3 2025 at Jaguar Health, roughly flat from $170000.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $170000.0 in Q1 2024 to a low of $170000.0 in Q1 2024.